[1]
|
Norata, G.D., Ballantyne, C.M. and Catapano, A.L. (2013) New Therapeutic Principles in Dyslipidaemia: Focus on LDL and Lp(a) Lowering Drugs. European Heart Journal, 34, 1783-1789. https://doi.org/10.1093/eurheartj/eht088
|
[2]
|
Reiner, Z., Catapano, A.L., De Backer, G., et al. (2011) ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). European Heart Journal, 32, 1769-1818. https://doi.org/10.1093/eurheartj/ehr158
|
[3]
|
廖玉华, 程翔. 非HDL-C与动脉粥样硬化性心血管病[J]. 临床心血管病杂志, 2014, 30(9): 743-745.
|
[4]
|
Gistera, A. and Ketelhuth, D.F.J. (2018) Lipid-Driven Immunometabolic Responses in Atherosclerosis. Current Opinion in Lipidology, 29, 375-380. https://doi.org/10.1097/MOL.0000000000000540
|
[5]
|
梁春. 强化降脂和抗炎“双达标”防治动脉粥样硬化性心血管疾病: 虚拟还是现实? [J]. 临床心血管病杂志, 2019, 35(9): 775-776.
|
[6]
|
Back, M., Yurdagul, A., Tabas, I., et al. (2019) Inflammation and Its Resolution in Atherosclerosis: Mediators and Therapeutic Opportunities. Nature Reviews Cardiology, 16, 389-406. https://doi.org/10.1038/s41569-019-0169-2
|
[7]
|
Collins, R., Reith, C., Emberson, J., Armitage, J., et al. (2016) Interpretation of the Evidence for the Efficacy and Safety of Statin Therapy. The Lancet, 388, 2532-2561. https://doi.org/10.1016/S0140-6736(16)31357-5
|
[8]
|
Lloyd-Jones, D.M., Morris, P.B., Ballantyne, C.M., Birtcher, K.K., Daly, D.D., DePalma, S.M., Minissian, M.B., Orringer, C.E. and Smith, S.C. (2017) Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. Journal of the American College of Cardiology, 68, 92-125. https://doi.org/10.1016/j.jacc.2016.03.519
|
[9]
|
Tang, Z.H., Peng, J., Ren, Z., et al. (2017) New Role of PCSK9 in Atherosclerotic Inflammation Promotion Involving the TLR4/NF-kB Pathway. Atherosclerosis, 262, 113-122. https://doi.org/10.1016/j.atherosclerosis.2017.04.023
|
[10]
|
Amato, M., Veglia, F., de Faire, U., et al. (2017) Carotid Plague-Thickness and Common Carotid IMT Show Additive Value in Cardiovascular Risk Prediction and Reclassification. Atherosclerosis, 263, 412-419.
https://doi.org/10.1016/j.atherosclerosis.2017.05.023
|
[11]
|
Bonetti, P.O., Lerman, L.O. and Lerman, A. (2003) Endothelial Dysfunction: A Marker of Atherosclerotic Risk. Arteriosclerosis, Thrombosis, and Vascular Biology, 23, 168-175. https://doi.org/10.1161/01.ATV.0000051384.43104.FC
|
[12]
|
Poredos, P., KekLjubec, A., Poredos, P. and Visnovic Poredos, A. (2006) Endothelial Dysfunction Predictor of Structural Changes of Arterial Wall in Type I Diabetes. International Angiology, 25, 280-286.
|
[13]
|
Cavieres, V., Valdes, K., Moreno, B., Moore-Carrasco, R. and Gonzalez, D.R. (2014) Vascular Hypercontractility and Endothelial Dysfunction before Development of Atherosclerosis in Moderate Dyslipidemia: Role for Nitric Oxide and Interleukin-6. American Journal of Cardiovascular Disease, 4, 114-122.
|
[14]
|
Makimattila, S. and Yki-Jarvinen, H. (2002) Endothelial Dysfunction in Human Diabetes. Current Diabetes Reports, 2, 26-36. https://doi.org/10.1007/s11892-002-0054-x
|
[15]
|
Nevelsteen, I., Van den Bergh, A., Van der Mieren, G., et al. (2013) NO-Dependent Endothelial Dysfunction in Type II Diabetes Is Aggravated by Dyslipidemia and Hypertension, But Can Be Restored by Angiotensin-Converting Enzyme Inhibition and Weight Loss. Journal of Vascular Research, 50, 486-497. https://doi.org/10.1159/000355221
|
[16]
|
Mihos, C.G., Pieda, A.M. and Santana, O. (2014) Cardiovascular Effects of Statins, beyond Lipid-Lowering Properties. Pharmacological Research, 88, 12-19. https://doi.org/10.1016/j.phrs.2014.02.009
|
[17]
|
Tesfamariam, B. (2006) The Effects of HMG-CoA Reductase Inhibitors on Endothelial Function. American Journal of Cardiovascular Drugs, 6, 115-120. https://doi.org/10.2165/00129784-200606020-00005
|